Last reviewed · How we verify
Observational, Cross-sectional, Multicenter Study to Evaluate Adherence to Different Treatment Regimens With Oral Bisphosphonates and Calcium and Vitamin D Supplements in Postmenopausal Osteoporosis. (OSTEOAD)
This study aims to evaluate the adherence of patients to combined treatment with bisphosphonates and calcium and vitamin D supplements, which is one of the usual treatments for postmenopausal osteoporosis. The study will consist of a single visit that will coincide with one of the patient's usual follow-up visits according to standard clinical practice. During this visit, information will be collected from the patient's medical history and an interview will be conducted using 3 questionnaires to assess how and how often the patient takes the treatment, possible forgetfulness, and whether or not the patient is satisfied with their current treatment.
Details
| Lead sponsor | Procare Health Iberia S.L. |
|---|---|
| Status | RECRUITING |
| Enrolment | 480 |
| Start date | 2025-03-03 |
| Completion | 2025-12 |
Conditions
- Post Menopausal Osteoporosis
Primary outcomes
- Intergroup adherence — Day 1
To evaluate intergroup adherence to the most common oral regimens used in the treatment of postmenopausal OP that combine BP and Ca/D supplements, using a 8-items Morisky Medication Adherence Scale
Countries
Spain